Avastin's uncertain future in breast cancer treatment.

Angiogenesis Inhibitors/adverse effects,therapeutic use Antibodies, Monoclonal/adverse effects,therapeutic use Antibodies, Monoclonal, Humanized Antineoplastic Combined Chemotherapy Protocols/therapeutic use Bevacizumab Biomarkers, Tumor/blood Breast Neoplasms/drug therapy Clinical Trials as Topic Drug Approval Europe Evidence-Based Medicine Female Humans International Cooperation Patient Selection Survival Analysis Treatment Failure Treatment Outcome United States United States Food and Drug Administration

Angiogenesis Inhibitors Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Biomarkers, Tumor Bevacizumab